GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Tempus AI Inc
Tempus AI uses artificial intelligence to analyze medical data, primarily in oncology. Its stock price reflects investors' faith in the potential of personalized medicine, but also the risks associated with data monetization and lengthy research cycles.
Share prices of companies in the market segment - Dna
Tempus is a company that uses AI to analyze medical data, primarily in oncology. We classify it as a member of the DNA sector. The chart below shows the overall dynamics of this segment, where investors are assessing the potential of data-driven, personalized medicine.
Broad Market Index - GURU.Markets
Tempus AI is a technology company that uses artificial intelligence and big data analytics to advance personalized medicine in oncology. As a healthcare innovator, it is included in the GURU.Markets index. The chart below reflects the overall market performance. Compare its stock performance to the overall trend in the medical technology sector.
Change in the price of a company, segment, and market as a whole per day
TEM - Daily change in the company's share price Tempus AI Inc
For Tempus AI, which uses AI to analyze medical data, daily price changes reflect high volatility and reactions to biotech news. While the chart of these fluctuations is unspectacular, it is an important component of the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Dna
Tempus AI, Inc. is a company at the intersection of artificial intelligence and medicine. This chart illustrates the high volatility of the biotech sector. Comparing it to TEM, whose business is based on big data analysis for oncology, helps us evaluate it as a barometer of innovation in personalized medicine.
Daily change in the price of a broad market stock, index - GURU.Markets
Tempus AI is a company using artificial intelligence to analyze medical and genomic data to personalize cancer treatments. This is a cutting-edge and speculative field. The chart below shows the high volatility typical of the AI sector, reflecting the enormous expectations and risks associated with Tempus.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Tempus AI Inc
Since its IPO, Tempus AI has been proving the strength of its platform for collecting and analyzing medical data for personalized oncology. Its year-over-year share price performance reflects investors' faith in the potential of big data and AI to revolutionize medicine.
Annual dynamics of market capitalization of the market segment - Dna
Tempus AI, Inc., a recent IPO, uses artificial intelligence to analyze medical data to improve cancer diagnosis and treatment. Its platform is at the intersection of technology and healthcare. The chart below shows how investors view its high growth potential and risks compared to the biotech sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Tempus AI is a company using artificial intelligence to analyze medical data to improve cancer diagnosis and treatment. It is a speculative investment in the future of personalized medicine. Its momentum is not tied to economics, but rather driven by scientific and commercial breakthroughs.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Tempus AI Inc
Tempus AI, a genetic testing and data analysis company, thrives on operational success. Monthly fluctuations on the chart reflect the growth in testing volumes, partnerships with pharmaceutical companies, and progress in using its data to develop new treatments.
Monthly dynamics of market capitalization of the market segment - Dna
Tempus AI, Inc. is a technology company building one of the world's largest clinical and molecular data libraries and an operating system for analyzing them. The dynamics of the DNA sector, shown in the graph, reflects the belief in personalized medicine. This allows us to appreciate how the Tempus platform helps doctors make more informed decisions in oncology and other diseases.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Tempus AI uses artificial intelligence and big data analysis to develop personalized medicine, primarily in oncology. As a biotech growth stock, it is highly sensitive to investor risk appetite. The chart below shows the overall market dynamics, which could drive significant swings in Tempus.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Tempus AI Inc
Shares of Tempus AI, a company that uses artificial intelligence and genetic data to treat cancer, have been experiencing high weekly volatility. Their stock is sensitive to news about partnerships with pharmaceutical companies, the publication of scientific studies confirming their model, and regulatory changes in the medical data industry.
Weekly dynamics of market capitalization of the market segment - Dna
Tempus AI shares, like those of other companies at the intersection of AI and medicine, are driven by the general hype and expectations surrounding these technologies. Investor sentiment toward the entire sector is creating strong waves. The chart will show whether the company stands out from this generally volatile trend.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Tempus AI uses artificial intelligence to analyze medical data, aiding in cancer treatment. It's a story of enormous hopes and risks. The chart will show how far the company's speculative stock price, driven by faith in an AI revolution in medicine, is detached from the market.
Market capitalization of the company, segment and market as a whole
TEM - Market capitalization of the company Tempus AI Inc
Tempus AI's market capitalization is a visual representation of investor expectations for the application of artificial intelligence in oncology. The chart reflects the company's valuation of its vast clinical and molecular dataset and its potential for personalized medicine. Its dynamics tell the story of how the market weighs the prospects for a revolution in cancer treatment against current financial metrics.
TEM - Share of the company's market capitalization Tempus AI Inc within the market segment - Dna
Tempus AI is a technology company that uses artificial intelligence to analyze medical and clinical data. Its share of the digital health sector's market capitalization reflects the potential of its personalized treatment platform. The chart shows investors' confidence in its future.
Market capitalization of the market segment - Dna
Tempus AI uses artificial intelligence to analyze medical data and personalize cancer treatment. The chart below shows the total value of the DNA analysis sector. Its growth reflects the belief that data is the key to defeating disease. Tempus is building its future on this cutting-edge frontier of science and technology.
Market capitalization of all companies included in a broad market index - GURU.Markets
The biotech companies represented in the chart are solving some of the most complex medical problems. Tempus AI uses artificial intelligence to analyze medical data, primarily in oncology. Its market cap reflects investors' belief that big data and AI can radically change approaches to cancer treatment.
Book value capitalization of the company, segment and market as a whole
TEM - Book value capitalization of the company Tempus AI Inc
Tempus AI's book value is the physical foundation of data-driven medicine. This chart reflects investments in building one of the world's largest bioinformatics libraries and cutting-edge genetic sequencing laboratories. These are tangible assets where biological samples are transformed into valuable information.
TEM - Share of the company's book capitalization Tempus AI Inc within the market segment - Dna
Tempus AI, at the intersection of medicine and data, has unique tangible assets. Its market share is determined by its cutting-edge laboratories for genome sequencing and biomaterial processing. This physical infrastructure generates unique data sets for the fight against cancer.
Market segment balance sheet capitalization - Dna
Tempus AI uses artificial intelligence to analyze medical data. Their main asset is a vast library of clinical and molecular data, as well as algorithms. Their book value chart demonstrates that their business is built on data, not expensive physical assets.
Book value of all companies included in the broad market index - GURU.Markets
Tempus AI's physical foundation consists of cutting-edge genomic sequencing laboratories and powerful data centers for medical data analysis. The diagram below shows how the company built this unique physical infrastructure at the intersection of biotechnology and artificial intelligence.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Tempus AI Inc
Tempus AI's assets are laboratories and data centers. The market valuation is a bet on their ability to revolutionize cancer treatment using AI and genomic data. The chart below shows how the market has valued this ambitious scientific and technological project.
Market to book capitalization ratio in a market segment - Dna
Tempus AI uses artificial intelligence to analyze medical data. As a tech company at the intersection of AI and medicine, its value lies in its data and algorithms. The chart shows how much its market valuation, based on potential, exceeds its current tangible assets.
Market to book capitalization ratio for the market as a whole
Tempus AI uses artificial intelligence to analyze medical data, aiding in cancer treatment. It's a company at the intersection of biotech and IT. Its market capitalization, compared to the average on the chart, is a bet on the future of medicine. Investors evaluate not its current assets, but the value of its vast database and the potential of its algorithms to create personalized therapy.
Debts of the company, segment and market as a whole
TEM - Company debts Tempus AI Inc
Tempus AI, a company at the intersection of medicine and artificial intelligence, is in an active investment phase. This chart shows how it is raising capital to build a massive library of clinical and molecular data and develop algorithms for personalized medicine. This strategy requires significant investments in data and technology for years to come.
Market segment debts - Dna
Tempus AI uses artificial intelligence to analyze medical data to aid in cancer treatment. This is a cutting-edge field that requires massive investments in technology and data collection, with no guarantee of immediate commercial success. This chart illustrates the level of financial risk inherent in disruptive biotech companies.
Market debt in general
Tempus AI, Inc. works at the intersection of medicine and artificial intelligence, building a database for personalized oncology. This chart, reflecting investor risk appetite, is important for early-stage companies. Like many biotech startups, Tempus uses raised capital, including debt, to finance data collection and development until it reaches profitability.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Tempus AI Inc
Tempus AI uses artificial intelligence to analyze medical data, which requires significant investment in technology and data collection. This chart shows the debt load of a young and currently unprofitable company. Debt is vital to funding growth. The main risk is whether the company can commercialize its technologies before the debt becomes unsustainable.
Market segment debt to market segment book capitalization - Dna
Tempus AI uses artificial intelligence to analyze medical and genetic data, aiding in cancer treatment. It's a cutting-edge but highly expensive business, requiring massive investments in data collection and R&D. The chart shows how aggressively the biotech and IT sector uses debt to finance revolutionary developments, and where Tempus fits within this landscape.
Debt to book value of all companies in the market
Tempus AI uses artificial intelligence to analyze medical data. Healthcare IT companies require massive investments in R&D and data. This chart shows the average debt load of the entire economy, allowing one to appreciate how Tempus AI's capital-intensive model differs from traditional industries.
P/E of the company, segment and market as a whole
P/E - Tempus AI Inc
Tempus AI is a company that uses artificial intelligence to analyze massive amounts of clinical and molecular data to personalize treatment, primarily in oncology. This chart reflects investor confidence in the future of data-driven medicine. Its high or negative values indicate that the market is evaluating breakthrough potential rather than current profitability.
P/E of the market segment - Dna
Tempus AI uses artificial intelligence to analyze massive amounts of clinical and molecular data to help doctors personalize cancer treatment. The company is at the intersection of medicine, big data, and AI. This chart shows the overall valuation for the DNA analysis sector, reflecting investor expectations for the revolution in precision medicine.
P/E of the market as a whole
Tempus AI uses artificial intelligence to analyze medical data, aiding in cancer diagnosis and treatment. This chart shows the overall valuation of tech companies, but TEM prioritizes breakthroughs in personalized medicine. The company's valuation reflects investors' belief that data and AI can revolutionize healthcare.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Tempus AI Inc
Tempus AI uses artificial intelligence to analyze large volumes of medical data to personalize treatment, particularly in oncology. This chart reflects investors' faith in a data-driven revolution in healthcare. Its dynamics represent a highly speculative estimate of future revenue from collaborations with pharmaceutical companies and hospitals in one of the most advanced fields of science.
%20P%2FE%20Tempus%20AI%20Inc&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Tempus-AI-Inc&v=1772557000680 "Chart of the company's future (projected) P/E Tempus AI Inc")
Future (projected) P/E of the market segment - Dna
Tempus AI uses artificial intelligence to analyze large volumes of medical and clinical data, aiding in personalized medicine, particularly in oncology. This chart compares the company's future revenue expectations with those of the biotech sector, reflecting investors' confidence in the potential of its platform to revolutionize diagnostics and treatment.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Dna&v=1772557000708 "Future (projected) P/E graph of the market segment - Dna")
Future (projected) P/E of the market as a whole
Tempus AI uses artificial intelligence to analyze medical and genetic data, aiding in cancer treatment. For a cutting-edge biotech company like Tempus, this graph of overall market expectations is important for access to capital. Investors' high risk appetite, typical of a bull market, allows them to fund the expensive research and development that underpins their business.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772557000718 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Tempus AI Inc
Tempus AI uses artificial intelligence to analyze massive amounts of clinical and molecular data to aid in cancer treatment. The company's business model is at the intersection of medicine and big data. This chart shows the financial results of its ambitious attempt to revolutionize personalized medicine using technology.
Profit of companies in the market segment - Dna
Tempus AI uses artificial intelligence to analyze medical data and develop personalized medicine. This chart reflects profitability in the innovative DNA and medical data analysis sector. For Tempus, at the forefront of science, this is an indicator of the willingness of the healthcare system and pharmaceutical companies to invest in breakthrough technologies.
Overall market profit
Tempus AI uses artificial intelligence to analyze massive amounts of clinical and molecular data to aid in cancer treatment. The company is at the forefront of personalized medicine. Its growth depends on the implementation of its technologies in oncology practice and partnerships with pharmaceutical companies. This overall market profitability graph has little bearing on its specific and rapidly growing niche.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Tempus AI Inc
Tempus AI uses artificial intelligence to analyze massive amounts of clinical and molecular data, aiding in cancer treatment. The company's revenue forecast reflects expectations for the growth of the personalized medicine market. Analysts estimate demand for its services from pharmaceutical companies and oncology centers, believing in the potential of its unique platform.
%20profit%20of%20the%20company%20Tempus%20AI%20Inc&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Tempus-AI-Inc&v=1772557000778 "Graph of future (projected) profit of the company Tempus AI Inc")
Future (predicted) profit of companies in the market segment - Dna
Tempus AI uses artificial intelligence to analyze medical data, aiding in personalized treatment, particularly in oncology. Future profits in this innovative sector depend on the implementation of these technologies in clinical practice and partnerships with pharmaceutical companies. This chart shows the extent to which analysts believe in the commercialization of AI in medicine and its potential to transform treatment approaches.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Dna&v=1772557000795 "Graph of future (predicted) profits of companies in a market segment - Dna")
Future (predicted) profit of the market as a whole
Tempus AI uses artificial intelligence to analyze medical data to aid in cancer treatment. This is a cutting-edge field dependent on biotech investment and the healthcare system's willingness to embrace innovation. This market profit forecast chart illustrates the overall investment climate, which is crucial for the growth of such capital-intensive companies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772557000810 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Tempus AI Inc
Tempus AI uses artificial intelligence to analyze medical data to personalize treatment, particularly in oncology. This chart shows a very high valuation relative to current revenue, which is typical for disruptive companies. Investors are betting on its potential to revolutionize medicine, evaluating not so much current sales as the potential for future revolution.
P/S market segment - Dna
Tempus AI uses artificial intelligence to analyze massive amounts of clinical and molecular data to help doctors personalize cancer treatment. This chart shows the average revenue valuation in the medtech sector, demonstrating the premium investors are willing to pay for Tempus's innovative platform and its potential to transform approaches to oncology.
P/S of the market as a whole
Tempus AI uses artificial intelligence to analyze large volumes of medical data to support personalized cancer treatment. The company's business model is at the intersection of biotechnology and IT. This chart reflects the overall revenue estimate, which can be used to analyze how high investor expectations for Tempus's future growth are compared to established companies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Tempus AI Inc
Tempus AI is a technology company that uses artificial intelligence to analyze massive volumes of medical and clinical data. This chart shows how investors estimate the company's future revenue. It reflects their belief in the potential of AI to revolutionize diagnostics and treatment, particularly in oncology.
%20P%2FS%20Tempus%20AI%20Inc&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Tempus-AI-Inc&v=1772557000872 "The graph of the company's future (projected) P/S Tempus AI Inc")
Future (projected) P/S of the market segment - Dna
Tempus AI uses artificial intelligence to analyze large volumes of clinical and molecular data to personalize treatment, primarily in oncology. Its valuation is based on the potential of its platform to transform approaches to medicine. This chart reflects investors' confidence in its ability to monetize data and become a leader in precision medicine.
%20P%2FS%20market%20segment%20graph%20-%20Dna&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Dna&v=1772557000875 "Future (projected) P/S market segment graph - Dna")
Future (projected) P/S of the market as a whole
Tempus AI uses artificial intelligence to analyze medical and genetic data, aiding in cancer treatment. Their business operates at the intersection of technology and healthcare. This market optimism influences Tempus through the willingness of investors and clinics to invest in cutting-edge technologies. Economic growth accelerates the adoption of innovation in medicine, which is a driver for Tempus.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772557000886 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Tempus AI Inc
Tempus AI uses artificial intelligence to analyze massive amounts of clinical and molecular data to help doctors personalize cancer treatment. This chart demonstrates the adoption of AI in medicine. The company's revenue growth, driven by providing data and analytics to pharmaceutical companies and hospitals, reflects the demand for more accurate and effective cancer treatments.
Sales of companies in the market segment - Dna
Tempus AI uses artificial intelligence to analyze massive amounts of clinical and molecular data to help doctors treat cancer and other diseases. It is a leading company at the intersection of medicine and big data. Their revenue breakdown shows how revenue is generated from genome sequencing, data licensing, and other analytical services.
Overall market sales
Tempus AI is a company that uses artificial intelligence to analyze medical and genomic data to personalize treatments, primarily in oncology. It operates at the intersection of technology and healthcare. This overall economic activity chart includes the rapidly growing biotech sector, where Tempus aims to revolutionize approaches to disease treatment.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Tempus AI Inc
Tempus AI uses artificial intelligence to analyze large volumes of molecular and clinical data to support personalized treatment, particularly in oncology. This chart reflects revenue projections, which depend on the number of contracts signed with pharmaceutical companies and medical institutions for the use of its platform.
%20sales%20of%20the%20company%20Tempus%20AI%20Inc&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Tempus-AI-Inc&v=1772557000924 "Schedule of future (projected) sales of the company Tempus AI Inc")
Future (projected) sales of companies in the market segment - Dna
Tempus AI uses artificial intelligence to analyze massive amounts of clinical and molecular data to personalize cancer treatment. This chart shows growth forecasts for the cutting-edge precision medicine and data analytics market in oncology. It illustrates expectations for the implementation of AI in healthcare, where Tempus aims to become a leader.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Dna&v=1772557000935 "Schedule of future (projected) sales of companies in the market segment - Dna")
Future (projected) sales of the market as a whole
Tempus AI uses artificial intelligence to analyze medical data, aiding in cancer treatment. This chart, which reflects overall economic forecasts, is important to the company as it impacts healthcare and biotech research funding. A stable economy allows hospitals and pharmaceutical companies to invest in cutting-edge technologies like the Tempus platform.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772557000950 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Tempus AI Inc
Tempus AI uses artificial intelligence to analyze medical and genetic data, aiding in cancer treatment. This chart shows the company's profitability during the growth investment phase. Profitability is currently limited by high costs of data collection, research, and development. The business model is aimed at creating a unique database that will be monetized in the future.
Market segment marginality - Dna
Tempus AI is a technology company that uses artificial intelligence to analyze massive volumes of molecular and clinical data for personalized medicine. The profitability of their business model depends on the value of analytics for physicians and pharmaceutical companies. This chart shows the progress in monetizing their unique data platform. A comparison with the industry highlights their innovative potential.
Market marginality as a whole
Tempus AI uses artificial intelligence to analyze medical and genomic data to aid in cancer treatment. It's a company at the intersection of biotech and AI. Its value is determined by the potential of its platform, not current profitability. This traditional economics chart reveals little about the breakthrough technologies Tempus is pursuing.
Employees in the company, segment and market as a whole
Number of employees in the company Tempus AI Inc
Tempus AI is at the intersection of technology and medicine, aiming to personalize cancer treatment using artificial intelligence and data analysis. This graph shows the growing team of scientists, physicians, and software engineers building one of the world's largest clinical and molecular data libraries to fight cancer.
Share of the company's employees Tempus AI Inc within the market segment - Dna
Tempus AI uses artificial intelligence to analyze massive amounts of clinical and molecular data to personalize treatment, particularly in oncology. This chart demonstrates its leadership in this emerging niche. It reflects the significant number of bioinformaticians, data scientists, and geneticists Tempus is attracting to build the world's largest cancer data library.
Number of employees in the market segment - Dna
Tempus AI uses artificial intelligence to analyze medical and genomic data to assist doctors in cancer treatment. This breakthrough approach is at the intersection of IT and medicine. This chart shows the rapidly growing team of data scientists and bioinformaticians who are shaping the future of personalized oncology, transforming vast amounts of data into life-saving solutions.
Number of employees in the market as a whole
Tempus AI uses artificial intelligence to analyze large volumes of medical and clinical data, helping doctors personalize treatment, particularly in oncology. The growth in overall employment, reflected in this chart, indicates a healthy economy capable of investing in advanced medical technologies. This creates a favorable environment for the implementation of innovative platforms like Tempus in hospitals and research centers.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Tempus AI Inc (TEM)
Tempus AI uses artificial intelligence to analyze medical data. This chart demonstrates the market's high appreciation for the potential of data and AI in medicine. The very high market cap per employee suggests that investors see value in the company's unique data sets and algorithms, rather than the number of people processing them.
%20of%20the%20company%20Tempus%20AI%20Inc%20(TEM)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Tempus-AI-Inc-TEM&v=1772557001047 "Chart of market capitalization per employee (in thousands of dollars) of the company Tempus AI Inc (TEM)")
Market capitalization per employee (in thousands of dollars) in the market segment - Dna
Tempus AI is a technology company that uses artificial intelligence and big data (including DNA) to advance personalized medicine. Its value lies in its data and algorithms. This chart shows the industry average. For an AI company of this size, it would likely be very high, reflecting the enormous cost of its data platform for a relatively small team.
%20by%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Dna&v=1772557001050 "Market capitalization per employee (in thousands of dollars) by market segment - Dna")
Market capitalization per employee (in thousands of dollars) for the overall market
Tempus AI uses artificial intelligence to analyze medical and clinical data to aid in cancer treatment. For a company at the intersection of AI and medicine, this metric reflects the enormous potential of its platform. A high employee rating is an investment in the future, where algorithms can discover new treatments, creating enormous value.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772557001060 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Tempus AI Inc (TEM)
Tempus AI is a company using artificial intelligence and big data to develop personalized medicine, primarily in oncology. This chart should be considered in the context of "R&D investments." The company is hiring hundreds of expensive data and AI specialists to build its platform. At this stage, this is likely an investment in future profits rather than current revenue generation.
%20Chart%20Tempus%20AI%20Inc%20(TEM)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Tempus-AI-Inc-TEM&v=1772557001079 "Company Profit Per Employee (in thousands of dollars) Chart Tempus AI Inc (TEM)")
Profit per employee (in thousands of dollars) in the market segment - Dna
Tempus AI is an R&D company using AI to analyze medical data (genomics, oncology). This chart shows the benchmark for "Dna" (AI-Biotech). In this sector, the benchmark is likely *negative*. Companies are burning billions collecting data and training models. Profit per employee (scientist, engineer) is the goal of the future.
%20in%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Dna&v=1772557001083 "Chart of profit per employee (in thousands of dollars) in the market segment - Dna")
Profit per employee (in thousands of dollars) for the market as a whole
Tempus AI uses artificial intelligence to analyze medical and clinical data to personalize cancer treatment. Human capital productivity data demonstrates the potential of MedTech. Here, a small team of scientists and programmers is creating a platform capable of processing massive amounts of data and transforming medicine, promising enormous value for their work.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772557001091 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Tempus AI Inc (TEM)
Tempus AI uses artificial intelligence to analyze medical and clinical data to aid in cancer treatment. This graph illustrates how a small team of highly skilled data and genetic specialists can generate significant revenue. The productivity figures here reflect the value of the unique platform and its data for pharmaceutical companies and physicians.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Tempus-AI-Inc-TEM&v=1772557001093 "Sales chart per company employee Tempus AI Inc (TEM)")
Sales per employee in the market segment - Dna
Tempus AI uses artificial intelligence to analyze massive amounts of medical data (especially oncology), helping doctors select treatments. It's at the intersection of biotech and IT. This chart shows how their model, which requires expensive data scientists and doctors, is already generating revenue, and how it compares to the industry average.
Sales per employee for the market as a whole
Tempus AI is a high-tech company at the intersection of medicine and data. They collect and analyze massive amounts of clinical and molecular data (including DNA) to personalize cancer treatments. Their business is AI and analytics. This chart shows how their team of scientists and analysts is beginning to monetize these unique data sets.
Short shares by company, segment and market as a whole
Shares shorted by company Tempus AI Inc (TEM)
Tempus AI (TEM) is a company aiming to revolutionize cancer treatment using AI. They collect massive amounts of clinical and genetic data to personalize therapy. This chart shows bearish bets. A high short position on TEM is a bet against the hype. Investors are doubtful of the company's business model, its lofty valuation, and its ability to monetize its data in the near future.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Tempus-AI-Inc-TEM&v=1772557001145 "Short Shares Chart for the Company Tempus AI Inc (TEM)")
Shares shorted by market segment - Dna
Tempus AI (TEM) is a company using artificial intelligence to analyze large volumes of clinical and molecular data to personalize cancer treatments. This chart highlights the general skepticism in the AI in medicine sector. It reflects investor concerns about the speed of commercialization of such technologies and regulatory hurdles facing the entire industry.
Shares shorted by the overall market
Tempus AI (TEM) is an ambitious company using AI and genomic data for personalized medicine. It's a classic "venture capital" story on the public market. This chart measures the overall level of fear. When pessimism rises, investors flee "dream stocks" that burn capital and promise profits in the distant future. Fear kills the appetite for such risky scientific projects.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Tempus AI Inc (TEM)
Tempus AI uses AI to analyze medical data, aiding in cancer treatment. This is a fast-growing but unprofitable sector. A chart above 70 may reflect euphoria surrounding AI in medicine. A range below 30 often reflects concerns about the path to profitability or reduced client R&D budgets.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Tempus-AI-Inc-TEM&v=1772557001192 "RSI 14 indicator chart for the company's stock Tempus AI Inc (TEM)")
RSI 14 Market Segment - Dna
Tempus AI (TEM) is a technology company that uses artificial intelligence to analyze massive amounts of clinical and molecular data. Their goal is to personalize cancer treatment. This chart tracks the overall sentiment in the DNA Analysis and AI in Medicine sector. It helps investors understand whether the TEM movement is a reaction to their developments or whether the entire sector is overheated by the hype surrounding medical AI.
RSI 14 for the overall market
Tempus AI (TEM) is a technology company that uses artificial intelligence and big data to analyze medical records and genomics for personalized medicine. This chart measures overall market euphoria. Like other AI stocks, TEM can become extremely overheated during periods of optimism and plummet when panic dominates the market.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast TEM (Tempus AI Inc)
Tempus AI (TEM) uses artificial intelligence to analyze massive amounts of clinical and genomic data, aiming to personalize treatment, particularly in oncology. It's a complex biotech company. This chart shows the average analyst forecast. Their price targets are an attempt to model future revenue growth from data and diagnostic testing.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-TEM-Tempus-AI-Inc&v=1772557001234 "A chart showing analyst consensus forecasts for the expected stock price. TEM (Tempus AI Inc)")
The difference between the consensus estimate and the actual stock price TEM (Tempus AI Inc)
Tempus AI is a technology company that uses artificial intelligence and analysis of massive genomic and clinical data sets to personalize cancer treatment. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the current price and the consensus target price, demonstrating whether experts believe in their data platform.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-TEM-Tempus-AI-Inc&v=1772557001245 "A chart showing the difference between the consensus forecast and the actual stock price. TEM (Tempus AI Inc)")
Analyst consensus forecast for stock prices by market segment - Dna
Tempus AI is a company at the intersection of medicine and AI. It collects vast amounts of clinical and genetic data to assist doctors in diagnosing and treating cancer. This chart shows the general expectations of analysts in the DNA (biotech) sector. It reflects whether experts believe in the commercialization of AI in medicine or consider it mere hype.
Analysts' consensus forecast for the overall market share price
Tempus AI uses artificial intelligence to analyze massive amounts of clinical and molecular data, aiding in cancer treatment. This is the cutting edge of MedTech. Market expectations, as seen in this chart, influence their ability to raise capital and the willingness of hospital systems (their clients) to pay for expensive tests in a potential downturn.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Tempus AI Inc
Tempus AI is a company at the intersection of AI and medicine. They have created a massive library of anonymized clinical and genetic data, which they use to personalize cancer treatment and accelerate R&D. This chart reflects the market's confidence in their AI platform. It measures their ability to sell their data and analytics to pharmaceutical companies for drug discovery.
AKIMA Market Segment Index - Dna
Tempus AI is a healthcare technology company. Tempus collects a massive library of clinical and molecular (DNA) data and uses AI to accelerate R&D (especially in oncology). This summary metric evaluates R&D. The graph shows the average value for the segment. This benchmark: how does Tempus's data platform (data + AI) differentiate it from the average pharma company?
The AKIM Index for the overall market
Tempus AI is a company that uses AI to analyze massive amounts of clinical and molecular data to personalize treatment, primarily in oncology. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this innovative scientific story, driven by the laws of biotech and AI, compares to general economic trends that influence risk appetite.
